Informējam, ka Sistēma pielāgota darbam ar interneta pārlūkprogrammu Internet Explorer (8. un jaunākām versijām) un Mozilla Firefox (3.6 un jaunākām versijām).
Izmantojot citu interneta pārlūkprogrammu, brīdinām, ka Sistēmas funkcionalitāte var tikt traucēta.
<p><span lang="EN-GB">This document specifies requirements for the biobanking of human natural killer (NK) cells derived from human pluripotent stem cells (hPSCs), including the requirements for the differentiaton, culture, characterization, quality control, storage, thawing and transport of NK cells.</span></p>
<p><span lang="EN-GB">Requirements for the collection of biological source material, the transport to and reception of biological source material and hPSCs at the biobank, as well as the establishment, expansion and QC of hPSCs are covered in ISO 24603.</span></p>
<p><span lang="EN-GB">This document is applicable to all organizations performing biobanking of human NK cells used for research and development in the life sciences.</span></p>
<p><span lang="EN-GB">This document does not apply to human NK cells for the purpose of in vivo application in humans, clinical applications or therapeutic use.</span></p>
<p><span lang="EN-GB">NOTE International, national or regional regulations or requirements or multiple of them can also apply to specific topics covered in this document.</span></p>
Reģistrācijas numurs (WIID)
86065
Darbības sfēra
<p><span lang="EN-GB">This document specifies requirements for the biobanking of human natural killer (NK) cells derived from human pluripotent stem cells (hPSCs), including the requirements for the differentiaton, culture, characterization, quality control, storage, thawing and transport of NK cells.</span></p>
<p><span lang="EN-GB">Requirements for the collection of biological source material, the transport to and reception of biological source material and hPSCs at the biobank, as well as the establishment, expansion and QC of hPSCs are covered in ISO 24603.</span></p>
<p><span lang="EN-GB">This document is applicable to all organizations performing biobanking of human NK cells used for research and development in the life sciences.</span></p>
<p><span lang="EN-GB">This document does not apply to human NK cells for the purpose of in vivo application in humans, clinical applications or therapeutic use.</span></p>
<p><span lang="EN-GB">NOTE International, national or regional regulations or requirements or multiple of them can also apply to specific topics covered in this document.</span></p>
